164 related articles for article (PubMed ID: 8503012)
1. Proliferation of human smooth muscle cells promoted by lipoprotein(a).
Grainger DJ; Kirschenlohr HL; Metcalfe JC; Weissberg PL; Wade DP; Lawn RM
Science; 1993 Jun; 260(5114):1655-8. PubMed ID: 8503012
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a), plasmin modulation, and atherogenesis.
Harpel PC; Hermann A; Zhang X; Ostfeld I; Borth W
Thromb Haemost; 1995 Jul; 74(1):382-6. PubMed ID: 8578490
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits.
Ichikawa T; Unoki H; Sun H; Shimoyamada H; Marcovina S; Shikama H; Watanabe T; Fan J
Am J Pathol; 2002 Jan; 160(1):227-36. PubMed ID: 11786416
[TBL] [Abstract][Full Text] [Related]
4. Conditioned medium from HepG2 cells transfected with human apolipoprotein(a) gene stimulates growth of human vascular smooth muscle cells: effects of overexpression of human apolipoprotein(a) gene.
Morishita R; Yamada S; Higaki J; Tomita N; Kida I; Aoki M; Moriguchi A; Hayashi S; Sakurabayashi I; Kaneda Y; Ogihara T
Hypertension; 1998 Aug; 32(2):215-22. PubMed ID: 9719045
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta and the protection from cardiovascular injury hypothesis.
Metcalfe JC; Grainger DJ
Biochem Soc Trans; 1995 May; 23(2):403-6. PubMed ID: 7672431
[No Abstract] [Full Text] [Related]
6. Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration.
Kojima S; Harpel PC; Rifkin DB
J Cell Biol; 1991 Jun; 113(6):1439-45. PubMed ID: 1828468
[TBL] [Abstract][Full Text] [Related]
7. Effects of wild-type (Trp72) and mutant (Arg72) apolipoprotein(a) kringle IV-10 on the proliferation of human arterial smooth muscle cells.
Yu H; Hong J; Wang B; Peng F; Li X; He C
Chin Med J (Engl); 2003 May; 116(5):721-6. PubMed ID: 12875689
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of vascular smooth muscle cell proliferation and migration by apolipoprotein(a) is dependent on inhibition of transforming growth factor-beta activation and on the presence of kringle IV type 9.
O'Neil CH; Boffa MB; Hancock MA; Pickering JG; Koschinsky ML
J Biol Chem; 2004 Dec; 279(53):55187-95. PubMed ID: 15498766
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) stimulates the proliferation of cultured human arterial smooth muscle cells through two pathways.
Miyata M; Biro S; Kaieda H; Tanaka H
FEBS Lett; 1995 Dec; 377(3):493-6. PubMed ID: 8549783
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein Lp(a) and atherothrombotic disease.
de la Peña-Díaz A; Izaguirre-Avila R; Anglés-Cano E
Arch Med Res; 2000; 31(4):353-9. PubMed ID: 11068075
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein(a): new insights into an atherogenic lipoprotein.
Bartens W; Wanner C
Clin Investig; 1994 Aug; 72(8):558-67. PubMed ID: 7819711
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta is activated by plasmin and inhibits smooth muscle cell death in human saphenous vein.
George SJ; Johnson JL; Smith MA; Angelini GD; Jackson CL
J Vasc Res; 2005; 42(3):247-54. PubMed ID: 15870504
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) induces cell growth in rat peritoneal macrophages through inhibition of transforming growth factor-beta activation.
Sato Y; Kobori S; Sakai M; Yano T; Higashi T; Matsumura T; Morikawa W; Terano T; Miyazaki A; Horiuchi S; Shichiri M
Atherosclerosis; 1996 Aug; 125(1):15-26. PubMed ID: 8831923
[TBL] [Abstract][Full Text] [Related]
14. Plasmin-mediated fibroblast growth factor-2 mobilisation supports smooth muscle cell proliferation in human saphenous vein.
George SJ; Johnson JL; Smith MA; Jackson CL
J Vasc Res; 2001; 38(5):492-501. PubMed ID: 11561151
[TBL] [Abstract][Full Text] [Related]
15. In vitro inhibition of fibrinolysis by apolipoprotein(a) and lipoprotein(a) is size- and concentration-dependent.
Knapp JP; Herrmann W
Clin Chem Lab Med; 2004; 42(9):1013-9. PubMed ID: 15497466
[TBL] [Abstract][Full Text] [Related]
16. Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cells.
Higazi AA; Lavi E; Bdeir K; Ulrich AM; Jamieson DG; Rader DJ; Usher DC; Kane W; Ganz T; Cines DB
Blood; 1997 Jun; 89(12):4290-8. PubMed ID: 9192751
[TBL] [Abstract][Full Text] [Related]
17. Dual effect of apolipoprotein(a) on plasmin(ogen)-induced apoptosis through modulation of cell detachment of adherent cells.
Ho-Tin-Noé B; Meilhac O; Rossignol P; Lijnen HR; Anglés-Cano E
Thromb Haemost; 2006 Jan; 95(1):142-50. PubMed ID: 16543973
[TBL] [Abstract][Full Text] [Related]
18. Novel therapeutic strategy for atherosclerosis: ribozyme oligonucleotides against apolipoprotein(a) selectively inhibit apolipoprotein(a) but not plasminogen gene expression.
Morishita R; Yamada S; Yamamoto K; Tomita N; Kida I; Sakurabayashi I; Kikuchi A; Kaneda Y; Lawn R; Higaki J; Ogihara T
Circulation; 1998 Nov; 98(18):1898-904. PubMed ID: 9799211
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen decreases the rate of proliferation of rat vascular smooth-muscle cells in culture by inducing production of transforming growth factor beta.
Grainger DJ; Weissberg PL; Metcalfe JC
Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):109-12. PubMed ID: 8363560
[TBL] [Abstract][Full Text] [Related]
20. Feedback mechanism of focal vascular lesion formation in transgenic apolipoprotein(a) mice.
Lawn RM; Pearle AD; Kunz LL; Rubin EM; Reckless J; Metcalfe JC; Grainger DJ
J Biol Chem; 1996 Dec; 271(49):31367-71. PubMed ID: 8940144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
